scorecardresearch
Add as a preferred source on Google
Monday, November 3, 2025
TopicRemdesivir

Topic: Remdesivir

Remdesivir trial discovers a Covid weak spot and why this success is critical

In episode 458 of #CutTheClutter, Shekhar Gupta explains the significance of the randomised trial of remdesivir's effectiveness on treating Covid-19.

This is how remdesivir, developed for Hepatitis C and Ebola, fights Covid-19

The experimental antiviral drug that was developed by US pharmaceutical company Gilead Sciences has shown that it leads to faster recovery in Covid-19 patients.

Remdesivir has clear-cut, positive effect on cutting Covid recovery time, says top US doctor

The claims of Dr Anthony Fauci come at the time a study in The Lancet has said ‘remdesivir is not associated with statistically significant clinical benefits’.

Why some experts want more data before they are convinced about remdesivir

Some experts say science has taken a back seat to optimism in the rush to find a way out of the coronavirus crisis that has paralysed economies around the world.

Remdesivir trial shows Covid-19 patients recover faster, could be first effective drug

The US trial looked at whether Gilead’s remdesivir helped people with Covid-19 recover faster than without it.

On Camera

The Kapoors’ love for food is stuff of legends. Netflix gets us a seat at a table

If there is one celebrity who has made talking about food both relatable and entertaining, it is Kareena Kapoor Khan.

Nvidia worth $5 trillion: What does it mean for the market?

The chipmaker at the heart of the AI revolution may be the most influential stock in Wall Street history. Nvidia has been the primary driver of the market’s gains since the start of 2023.

Launch of India’s heaviest comms satellite is a level up for its soaring military ambitions. Here’s how

ISRO’s LMV3 rocket set off the CMS-03 satellite from Sriharikota Sunday. It weighs 4,410 kg, will primarily serve Indian Navy and has a life of at least 15 years.

Trump’s trade wars have rewritten powerplay, but India didn’t get the memo

This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.